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some Light on  
the Photobiology of Vitamin D
Antony R. Young1
In this issue, Bogh et al. report a study that begins to address the important public 
health question of skin surface area and UVB exposure dose, related to erythema, 
necessary to achieve a given level of vitamin D status. They demonstrate the impor-
tance of baseline vitamin D status in conducting such studies. A smaller substudy 
suggests that skin pigment is not a barrier to vitamin D photosynthesis.
Journal of Investigative Dermatology (2010) 130, 346–348. doi:10.1038/jid.2009.419
Introduction
The benefits of vitamin D and how best 
to obtain and maintain optimal lev-
els are highly controversial topics that 
have enormous potential implications 
for human health. Nature has provided 
humans with two sources of vitamin D: 
solar UVB radiation and diet. However, 
most foods provide very little vitamin D, 
especially in typical Western diets. The 
exception is oily fish. Manmade interven-
tions include food fortification in some 
countries, supplementation, and the use 
of tanning devices with UVB. Any discus-
sion on vitamin D status should be based 
on facts. There is a surprising lack of care-
ful, published investigation (as opposed 
to observation/extrapolation/calculation) 
into the photobiology of vitamin D in 
vivo and its interaction with skin color. 
Furthermore, there is a lack of data that 
compare the effects of UVR with other 
approaches to maintaining vitamin D 
status performed in the same laboratories 
to minimize experimental variation.
the significance of this study
The study by Bogh et al. (2010, this issue) 
is a welcome and timely addition to our 
knowledge in the photobiology field. 
The baseline data show that 85% of 
182 people screened for the study were 
either vitamin D (25(OH)D) insufficient 
(67% < 50 nmol l-1) or deficient (18% < 
25 nmol l-1) in Denmark at 56°N during 
the winter. The limitation of these defi-
nitions of vitamin D status is discussed 
in this issue’s Editorial, by Reddy and 
Gilchrest (2010). The backs and chests 
of volunteers with skin types I–VI were 
exposed to three standard erythema 
doses (SEDs) of UVB for 4 days over 
1 week. The UVB source used was very 
rich in the spectral region that converts 
7-dehydrocholesterol to pre–vitamin D 
in the skin. The sites exposed represent 
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darker skin types, which included V and 
VI, had lower doses. This study should be 
confirmed with a larger sample size, and 
broadened in its remit, but it calls into 
question much of the dogma about the 
relationship between pigmentation and 
vitamin D status, and perhaps even the 
hypothesis that vitamin D was a major 
factor in the evolution of skin color (Yuen 
and Jablonski, 2009). However, the data 
of Bogh et al. are in contrast with those 
recently published by Armas et al. (2007) 
in a larger study. Armas et al. exposed 
90% of the body surface area three times 
per week for 4 weeks. The doses given to 
skin types I/II would be expected to be in 
the MED range, and doses up to fourfold 
greater were given to individuals with 
darker skin types. The estimated increase 
of 25(OH)D in skin types I/II for a dose 
of 30 mJ/cm2 over 4 weeks was compa-
rable to that obtained in 1 week in Bogh 
and colleagues’ study. Higher doses 
were required for darker skin types. Thus, 
overall, the outcomes of the two studies, 
with very different designs, are contra-
dictory. However, it should be noted 
that the study population of Armas et al. 
(2007) indicated a relationship between 
skin color and baseline 25(OH)D, with 
higher values for fairer skin types. The 
current study shows that this difference 
in baseline 24(OH)D levels could have 
influenced the outcome.
How best to obtain vitamin D
Some three decades ago, some studies 
compared daily UVR with daily vitamin 
D supplementation, at different doses, 
for 3 weeks in vitamin D-deficient/
insufficient people (Stamp et al., 1977). 
The UVR details are not comprehensive 
but would appear to be for whole-body 
exposure to a source with a peak at 
290 nm. The initial “dose” was 1 min-
ute, on dorsal and ventral surfaces, but 
this was increased by 1 minute each 
day, except when erythema was present 
(Stamp, 1975), indicating that the doses 
exposed to about 250 SEDs per working 
year, mostly in the spring and sum-
mer (Godar et al., 2001). This can be 
increased by 78 SEDs (i.e., about 30%) 
with a 3-week vacation (i.e., by 3.7 SEDs 
per day). It is perhaps surprising that even 
studies in sunny climates have demon-
strated suboptimal vitamin D status. This 
conundrum remains to be investigated 
and explained.
It is often said that short solar expo-
sures to the face and the back of the 
hands are adequate to maintain optimal 
vitamin D status, but this does not seem 
to have been experimentally verified. 
Using the technique of Augustsson et al. 
(1992), this would be equivalent to ~10% 
of the body surface and would increase 
to ~20% if the lower arms are included, 
which is still less than the ~25% sur-
face area in Bogh and colleagues’ study. 
Whether this is sufficient with lower 
UVR doses, which are more typical of 
daily exposure at given latitudes, over 
a longer period of time, remains to be 
tested under laboratory and/or field con-
ditions. In this context it should also be 
noted that an SED of solar UVR will be 
less effective at vitamin D synthesis than 
an SED from the very UVB-rich source 
used in this study. This is because UVA 
in sunlight makes a much greater contri-
bution to erythema than with the source 
used by Bogh et al.
Skin color and vitamin D synthesis
Of particular interest is the substudy 
on the effect of pigmentation (see 
Table 2 in the article by Bogh et al.) on 
vitamin D synthesis; people with darker 
skin tend to have suboptimal vitamin 
D status. Although the sample size is 
small (n = 9 pairs matched with similar 
baseline 25(OH)D), the data indicate 
that skin type and measured pigmenta-
tion have no effect on the synthesis of 
vitamin D after exposure to the same 
fixed doses of UVB; this means that from 
an erythemal (MED) point of view the 
~25% body surface area as estimated by 
the approach of Augustsson et al. (1992). 
It should be stressed that an SED is inde-
pendent of personal UVR sensitivity and 
is a measure of erythemal efficacy that is 
independent of source spectrum. A dose 
of 3 SEDs is equivalent to about 1 mini-
mal erythema dose (MED) in skin types 
I/II and would be suberythemogenic 
(approximately 0.5 MED) in skin types 
III/IV (Harrison and Young, 2002). The 
authors show that baseline 25(OH)D is 
the determinant of the response to UVB 
exposure. The lower the baseline level, 
the greater the response, which supports 
homeostatic control. The regression line 
in Figure 3 in the article by Bogh et al. 
indicates that individuals in the insuf-
ficient/deficient baseline range had an 
increase of 20–30 nmol l-1 25(OH)D, 
a very substantial response, in about 
1 week. This essentially brought people 
who were insufficient into sufficiency 
and those who were deficient into insuf-
ficiency. However, it must be stressed 
that a relatively large surface area was 
exposed, and, at least in skin types I/
II, the exposure doses would have been 
approximately erythemogenic.
The UVR doses used in the study by 
Bogh and co-workers should be placed 
into context. The same authors have per-
formed several studies in which UVR 
exposure was measured over extend-
ed periods in different populations in 
spring/summer in Denmark (56°N) using 
time-stamped personal electronic dosim-
eters. In people working indoors without 
engaging in sun-seeking behavior, the 
median daily dose was 0.3 SED (range: 
0–3.9) on working days and 0.6 SED 
(range: 0.1–3.5 SED) on their days off 
(Thieden et al., 2004). The measurements 
were taken on subjects’ wrists, and it is 
estimated that the dose to the face is two-
fold greater. Thus, the doses used in Bogh 
and colleagues’ study were 5–10 times 
higher than median wrist exposures at 
the same latitude. Not surprisingly, high-
er daily exposures have been measured 
in Queensland, Australia, with, for exam-
ple, home workers in Brisbane (27.4°S) 
having weekday shoulder exposure 
medians of 2.0–8.0 SEDs, depending on 
the time of year. Outdoor workers at the 
same latitude showed values of 3.0–10.0 
SEDs (Parisi et al., 2000). It has been 
estimated that the average American is 
Clinical Implications
•  Baseline 25(OH)D is a determinant of UVB-induced vitamin D synthesis.
•  Vitamin D photosynthesis is independent of skin pigmentation for a 
fixed UVB dose and similar baseline 25(OH)D level.
•  Is adventitious solar exposure of face and hands sufficient to maintain 
vitamin status?
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understanding of the relationship among 
UVR spectrum, skin area and exposure 
dose, skin color, tanning, photoprotec-
tion, and vitamin D outcome. Some of 
these issues in the context of risk/ben-
efit are currently being investigated in 
a multinational European Community–
funded project, “ICEPURE: The Impact of 
Climatic and Environmental Factors on 
Personal Ultraviolet Radiation Exposure 
and Human Health” (see http://www.
icepure.eu for details). Furthermore, we 
need a much better understanding of the 
relationship between the maintenance 
of vitamin D status by UVB versus diet/
supplementation and their interactions.
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ommended by the US Department of 
Health and Human Services and the US 
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Much of the advice pertaining to 
“safe sun” is based on the prevention of 
erythema because it is a readily accessi-
ble clinical readout, and sunburn is a risk 
factor for malignant melanoma in suscep-
tible skin types. It is possible to compare, 
in theory, the relative risks and benefits 
of solar exposure using action spectra 
(wavelength dependence) for erythema 
and the synthesis of pre–vitamin D (not 
25(OH)D) as biological weighting func-
tions with solar spectra with different 
UVB/UVA ratios. The amount of UVB 
increases with the height of the sun, 
which is dependent on latitude, sea-
son, and time of day. Such calculations 
indicate that the optimal benefit-to-risk 
ratio occurs when the sun is high in the 
sky (Sayre and Dowdy, 2007), which is 
when people are advised to avoid the 
sun (e.g., about noon). These calcula-
tions are based on action spectra, which 
are likely to have large margins of error, 
and it would be desirable to test these 
results under field or laboratory condi-
tions using 25(OH)D as the readout.
conclusions
The dermatology community is very 
mindful of the well-established detri-
mental effects of UVB. The commu-
nity is increasingly aware of the role of 
UVB in vitamin D synthesis but is still 
skeptical of many of the health benefits 
attributed to vitamin D. Researchers are 
justifiably concerned about the misuse 
of information for financial gain or the 
inadvertent promotion of sun-seeking/
tanning behavior. However, much work 
remains to be done in risk-versus-benefit 
assessment of UVR exposure, which 
will depend on a range of individual/
demographic/cultural/geographic factors 
and on the communication of research 
outcomes and advice to the public. 
There is a clear need for a much better 
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Cutaneous T-Cell Lymphoma:  
Two Faces of the same Coin
Magdalena B. Wozniak1 and Miguel Á. Piris1
Primary cutaneous anaplastic large-cell lymphoma (C-ALCL) and cutaneous 
peripheral T-cell lymphoma not otherwise specified (C-PTL-NOs) are cutaneous 
T-cell lymphomas with distinct clinical behaviors. Whereas C-ALCL has a favorable 
prognosis with frequent spontaneous disease regression, C-PTL-NOs runs a more 
aggressive course. The molecular pathogenesis of these cutaneous T-cell lymphoma 
types has not yet been studied in detail. In this issue, van Kester et al. report new 
imbalances that could contribute to our understanding of the differences between 
these two lymphoma types.
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Cutaneous T-cell lymphomas (CTCLs) 
are non-Hodgkin´s lymphomas char-
